{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:05:51Z","timestamp":1762506351555,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.eururo.2014.04.008","type":"journal-article","created":{"date-parts":[[2014,4,28]],"date-time":"2014-04-28T18:00:10Z","timestamp":1398708010000},"page":"689-691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["All Bacillus Calmette-Gu\u00e9rin (BCG) Strains Are Equal, but Some BCG Strains Are More Equal Than Others"],"prefix":"10.1016","volume":"66","author":[{"given":"Aidan P.","family":"Noon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Girish S.","family":"Kulkarni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eururo.2014.04.008_bib0005","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","article-title":"Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors","volume":"116","author":"Morales","year":"1976","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2014.04.008_bib0010","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1464-410X.1987.tb04876.x","article-title":"Intravesical BCG therapy in the management of multiple superficial bladder carcinoma. Comparison between Glaxo and Pasteur strains","volume":"59","author":"Kaisary","year":"1987","journal-title":"Br J Urol"},{"key":"10.1016\/j.eururo.2014.04.008_bib0015","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1097\/01.ju.0000154354.06892.ba","article-title":"Bacillus calmette-guerin Tokyo172 substrain for superficial bladder cancer: characterization and antitumor effect","volume":"173","author":"Ikeda","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2014.04.008_bib0020","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/nrurol.2013.194","article-title":"BCG immunotherapy for bladder cancer--the effects of substrain differences","volume":"10","author":"Gan","year":"2013","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.eururo.2014.04.008_bib0025","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nrurol.2012.252","article-title":"Bladder cancer in 2012: challenging current paradigms","volume":"10","author":"Noon","year":"2013","journal-title":"Nat Rev Urol"},{"key":"10.1016\/j.eururo.2014.04.008_bib0060","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.eururo.2014.02.061","article-title":"Bacillus Calmette-Gu\u00e9rin strain differences have an impact on clinical outcome in bladder cancer immunotherapy","volume":"66","author":"Rentsch","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.eururo.2014.04.008_bib0035","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0022-5347(01)67606-7","article-title":"A randomized study of intravesical mitomycin C, bacillus Calmette-Guerin Tice and bacillus Calmette-Guerin RIVM treatment in pTa-pT1 papillary carcinoma and carcinoma in situ of the bladder","volume":"153","author":"Vegt","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.eururo.2014.04.008_bib0040","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1111\/j.1464-410X.1994.tb07548.x","article-title":"Marker tumour response to Evans and Pasteur bacille Calmette-Guerin in multiple recurrent pTa\/pT1 bladder tumours: report from the Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party)","volume":"73","author":"Fellows","year":"1994","journal-title":"Br J Urol"},{"key":"10.1016\/j.eururo.2014.04.008_bib0045","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1464-410X.1992.tb15486.x","article-title":"Intravesical BCG treatment for superficial bladder cancer: long-term results using two different strains of BCG","volume":"69","author":"Mukherjee","year":"1992","journal-title":"Br J Urol"},{"key":"10.1016\/j.eururo.2014.04.008_bib0050","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/0974-7796.106873","article-title":"Comparable effect with minimal morbidity of low-dose Tokyo 172 strain compared with regular dose Connaught strain as an intravesical bacillus Calmette-Guerin prophylaxis in nonmuscle invasive bladder cancer: results of a randomized prospective comparison","volume":"5","author":"Inamoto","year":"2013","journal-title":"Urol Ann"},{"key":"10.1016\/j.eururo.2014.04.008_bib0055","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.juro.2013.01.084","article-title":"A prospective comparative study of intravesical bacillus Calmette-Guerin therapy with the Tokyo or Connaught strain for nonmuscle invasive bladder cancer","volume":"190","author":"Sengiku","year":"2013","journal-title":"J Urol"}],"container-title":["European Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283814003753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0302283814003753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T13:04:34Z","timestamp":1759583074000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0302283814003753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0302283814003753"],"URL":"https:\/\/doi.org\/10.1016\/j.eururo.2014.04.008","relation":{},"ISSN":["0302-2838"],"issn-type":[{"type":"print","value":"0302-2838"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"All Bacillus Calmette-Gu\u00e9rin (BCG) Strains Are Equal, but Some BCG Strains Are More Equal Than Others","name":"articletitle","label":"Article Title"},{"value":"European Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2014.04.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.eururo.2014.02.061","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 European Association of Urology. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}